Literature DB >> 10588085

Modeling the impact of subclinical measles transmission in vaccinated populations with waning immunity.

J Mossong1, D J Nokes, W J Edmunds, M J Cox, S Ratnam, C P Muller.   

Abstract

An increasing body of evidence suggests that a substantial proportion of individuals who respond to measles vaccine display an antibody boost accompanied by mild or no symptoms on exposure to wild virus. It is unknown whether this emerging class of individuals can support transmission. The epidemiologic consequences of vaccinated individuals able to transmit virus are investigated using a mathematical model. Parameters for this model are estimated using regression analysis on a Canadian serologic data set. The authors confirm that neutralizing antibodies are decaying significantly in absence of circulating virus. Based on a protective threshold plaque reduction neutralization (PRN) titer of 120, the authors estimate the mean duration of vaccine-induced protection in absence of reexposure to be 25 years (95% confidence interval (CI) 18, 48). After long-term absence of circulating virus, the mathematical model predicts that 80% (95% CI 65, 91) of all seroconverted vaccinees have titers below the protective threshold. In this case, elimination of measles virus cannot be achieved by a single-dose routine vaccination strategy if the basic reproduction number in vaccinated individuals exceeds 1.24 (95% CI 1.10, 1.53). For this reason, there is a need to establish the intensity and duration of infectiousness in vaccinated individuals.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10588085     DOI: 10.1093/oxfordjournals.aje.a009951

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  34 in total

1.  Humoral and cellular immune responses to measles and tetanus: the importance of elapsed time since last exposure and the nature of the antigen.

Authors:  Patricia O Viana; Erika Ono; Maristela Miyamoto; Reinaldo Salomao; Beatriz T Costa-Carvalho; Lily Y Weckx; Maria Isabel de Moraes-Pinto
Journal:  J Clin Immunol       Date:  2010-04-20       Impact factor: 8.317

2.  Interpreting serological surveys using mixture models: the seroepidemiology of measles, mumps and rubella in England and Wales at the beginning of the 21st century.

Authors:  A J Vyse; N J Gay; L M Hesketh; R Pebody; P Morgan-Capner; E Miller
Journal:  Epidemiol Infect       Date:  2006-05-02       Impact factor: 2.451

3.  Implications of vaccination and waning immunity.

Authors:  J M Heffernan; M J Keeling
Journal:  Proc Biol Sci       Date:  2009-03-04       Impact factor: 5.349

Review 4.  Biological feasibility of measles eradication.

Authors:  William J Moss; Peter Strebel
Journal:  J Infect Dis       Date:  2011-07       Impact factor: 5.226

5.  Immuno-epidemiology of a population structured by immune status: a mathematical study of waning immunity and immune system boosting.

Authors:  M V Barbarossa; G Röst
Journal:  J Math Biol       Date:  2015-04-02       Impact factor: 2.259

6.  Reduced immunity to measles in adults with major depressive disorder.

Authors:  Bart N Ford; Robert H Yolken; Faith B Dickerson; T Kent Teague; Michael R Irwin; Martin P Paulus; Jonathan Savitz
Journal:  Psychol Med       Date:  2018-03-19       Impact factor: 7.723

7.  Fully vaccinated children are rare: immunization coverage and seroprevalence in Austrian school children.

Authors:  Markus Ringler; Georg Göbel; Johannes Möst; Kurt Weithaler
Journal:  Eur J Epidemiol       Date:  2003       Impact factor: 8.082

Review 8.  The genetic basis for interindividual immune response variation to measles vaccine: new understanding and new vaccine approaches.

Authors:  Iana H Haralambieva; Inna G Ovsyannikova; V Shane Pankratz; Richard B Kennedy; Robert M Jacobson; Gregory A Poland
Journal:  Expert Rev Vaccines       Date:  2013-01       Impact factor: 5.217

9.  The emergence of translational epidemiology: from scientific discovery to population health impact.

Authors:  Muin J Khoury; Marta Gwinn; John P A Ioannidis
Journal:  Am J Epidemiol       Date:  2010-08-05       Impact factor: 4.897

10.  A target site for template-based design of measles virus entry inhibitors.

Authors:  Richard K Plemper; Karl J Erlandson; Ami S Lakdawala; Aiming Sun; Andrew Prussia; Jutatip Boonsombat; Esin Aki-Sener; Ismail Yalcin; Ilkay Yildiz; Ozlem Temiz-Arpaci; Betul Tekiner; Dennis C Liotta; James P Snyder; Richard W Compans
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-31       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.